Use data of all dosed subjects [Two-Stage / GS Designs]

posted by Helmut Homepage – Vienna, Austria, 2019-09-19 15:16 (1104 d 16:57 ago) – Posting: # 20617
Views: 6,596

Hi Elena,

» […] What combined data should be evaluated after stage 2 completion: ONLY for Cmax or for Cmax and AUCt?

Whatever drives the second stage, you have to use all data (Cmax and AUC). Whilst from a statistical perspective there would be no need to assess AUC (already BE in the first stage) no regulator would accept that. Once you dosed subjects, you have to use the data. No way out.

Dif-tor heh smusma 🖖 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,391 posts in 4,685 threads, 1,595 registered users;
online 7 (0 registered, 7 guests [including 5 identified bots]).
Forum time: Wednesday 08:13 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5